Summary
Hypothalamic growth hormone-releasing hormone (GHRH) neurons stimulate pulsatile pituitary growth hormone (GH) secretion and thereby determine glucose homeostasis and growth in children and eventually adult height. Conversely, growth hormone deficiency is potentially lethal in neonates, and can lead to short stature and significant morbidity later in life. However, the mechanisms of growth hormone deficiency are incompletely understood, since pituitary cells and hypothalamic GHRH neurons are virtually impossible to obtain for disease modelling. The aim of my proposal is to differentiate GHRH neurons from human embryonic stem cells (hESCs), which can self-renew indefinitely in culture while maintaining the ability to become almost any cell type in the human body. My proposal is comprised of three distinct work packages (WP1-3). In WP1, I will develop a conventional growth factor-based protocol for GHRH neuron differentiation by taking advantage of the existing knowledge on signals regulating hypothalamic development. In WP2, I will use RNA sequencing data from WP1 to directly differentiate hESCs to GHRH neurons by CRISPR-dCas9-based gene activation system (CRISPRa), which can temporally control the transcription of desired endogenous loci. In WP3, I will characterize the endocrine and electrophysiological properties of GHRH cells from WP1 and WP2. My project will provide a platform to model genetic causes of GH deficiency, and is expected to be applicable for human growth-modulating drug discovery. The three WPs will be carried out in an excellent training environment at the Stem Cells and Metabolism Research Program at the Research Program Unit (research flagship program of the University of Helsinki, Finland).
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/894596 |
| Start date: | 01-09-2020 |
| End date: | 31-08-2022 |
| Total budget - Public funding: | 202 680,96 Euro - 202 680,00 Euro |
Cordis data
Original description
Hypothalamic growth hormone-releasing hormone (GHRH) neurons stimulate pulsatile pituitary growth hormone (GH) secretion and thereby determine glucose homeostasis and growth in children and eventually adult height. Conversely, growth hormone deficiency is potentially lethal in neonates, and can lead to short stature and significant morbidity later in life. However, the mechanisms of growth hormone deficiency are incompletely understood, since pituitary cells and hypothalamic GHRH neurons are virtually impossible to obtain for disease modelling. The aim of my proposal is to differentiate GHRH neurons from human embryonic stem cells (hESCs), which can self-renew indefinitely in culture while maintaining the ability to become almost any cell type in the human body. My proposal is comprised of three distinct work packages (WP1-3). In WP1, I will develop a conventional growth factor-based protocol for GHRH neuron differentiation by taking advantage of the existing knowledge on signals regulating hypothalamic development. In WP2, I will use RNA sequencing data from WP1 to directly differentiate hESCs to GHRH neurons by CRISPR-dCas9-based gene activation system (CRISPRa), which can temporally control the transcription of desired endogenous loci. In WP3, I will characterize the endocrine and electrophysiological properties of GHRH cells from WP1 and WP2. My project will provide a platform to model genetic causes of GH deficiency, and is expected to be applicable for human growth-modulating drug discovery. The three WPs will be carried out in an excellent training environment at the Stem Cells and Metabolism Research Program at the Research Program Unit (research flagship program of the University of Helsinki, Finland).Status
CLOSEDCall topic
MSCA-IF-2019Update Date
28-04-2024
Images
No images available.
Geographical location(s)
